+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DPIV"

Drug Overview: DPIV - Product Thumbnail Image

Drug Overview: DPIV

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
  • Global
From
Drug Overview: V180 - Product Thumbnail Image

Drug Overview: V180

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Disease Analysis: Dengue Vaccines - Product Thumbnail Image

Disease Analysis: Dengue Vaccines

  • Report
  • March 2021
  • 40 Pages
  • Global
Disease Overview: Dengue Vaccines - Product Thumbnail Image

Disease Overview: Dengue Vaccines

  • Drug Pipelines
  • January 2018
  • 83 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

DPIV (Disease Prevention and Immunization Vaccines) are a type of vaccine used to prevent and protect against infectious diseases. They are typically administered to individuals through injection, although some may be administered orally or nasally. DPIVs are designed to stimulate the body's immune system to produce antibodies that will protect against a particular disease. They are typically used to protect against diseases such as measles, mumps, rubella, polio, and hepatitis B. DPIVs are an important part of public health initiatives, as they can help reduce the spread of infectious diseases and protect vulnerable populations. They are also used to protect travelers from diseases that may be present in other countries. The DPIV market is highly competitive, with many companies offering a variety of vaccines. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Novartis. Other companies in the market include AstraZeneca, Johnson & Johnson, and CSL. Show Less Read more